Osteoarthritis is the most commonly diagnosed degenerative joint disease affecting the joints, especially in elderly people.
Signs and symptoms of osteoarthritis might include joint stiffness and discomfort often with a sensation of a grinding in the affected joint. Rheumatoid arthritis, an auto-immune disease that affects the body as a whole, may also lead to joint destruction.
Treatments with a favourable side effect profile
Treatment often involves medication to ease the inflammation and reduce the pain in the joints. Many patients will receive Non Steroidal Anti Inflammatory Drugs, or NSAIDs, for this purpose. A major risk related to the use of NSAIDs is that they may cause unpleasant or dangerous side effects, such as irritation or bleeding in the intestinal tract.
Scientific discovery paved the way for more COX-2 selective treatments with a favourable side effect profile. Differences in the profiles between meloxicam and other selective COX-2 inhibitors are explained by its different chemical structure and its unique pharmacological action at the COX-2 channel.
Products
Mobic®, Mobec®, Mobicox®, Movalis®, Movatec® (meloxicam) is a non-steroidal anti-inflammatory drug indicated for
- Symptomatic treatment of painful osteoarthritis (arthrosis, degenerative joint disease)
- Symptomatic treatment of rheumatoid arthritis
- Symptomatic treatment of ankylosing spondylitis
Disclaimer:
We recognise that the Internet serves a global community. The pharmaceutical industry, however, is subject to country specific regulatory considerations, which affect the information we can provide on our products. In addition the registration status of pharmaceutical products may not be the same in different regions of the world and the approved product labels may also differ according to country specific requirements.
Therefore please check the registration details of this/these product(s) locally in order to get up-to-date information.